POST LEONARD E sold $73K of CGON
POST LEONARD E sold 1,000 shares of CG Oncology, Inc. (CGON) at $72.98 on 2026-09-15 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The filing provides a transparent view of insider activity but offers little actionable insight.
Market read
Minor insider sale with limited market impact.
What to watch
Potential upcoming financing needs or strategic shifts not disclosed in the filing.
Background
SEC Form 4 filing discloses insider transactions required by regulation.
Ticker impact
Director Leonard Post sold 1,000 shares for $72,980 via a 10b5-1 plan, reducing his stake to zero.
negligible impact on price
A $73K sale by a director is a routine liquidity event with no material change in ownership.
Market effects
None; the sale does not affect the oncology sector broadly.
None; limited to CG Oncology shareholders.
None; the transaction is company‑specific and small.
Counterpoint
If the director is exiting due to undisclosed concerns, the stock could face downside pressure.
Key entities
- CompanyCG Oncology, Inc.
Biotech firm listed on NASDAQ under ticker CGON.
- DirectorLeonard E. Post
Insider who sold his entire shareholding.